Mass Screening for Inborn Errors of Metabolism

Research output: Contribution to journalReview article

Abstract

Neonatal mass screening is a project aiming at the prevention of disorders by discovering and treating diseases which damage health left untreated in all newborns. The bacterial inhibition assay (BIA) was developed in about .1961 and used as the Guthrie method for a long time, but it was replaced by tandem mass spectrometry due to the recent development of mass spectrometers, and its nationwide introduction in Japan was completed. With this introduction, 13 diseases were newly included in screening. Fatty acid and organic acid metabolic disorders and urea cycle disorders were included, and favorable results have been obtained.

Original languageEnglish
Pages (from-to)441-449
Number of pages9
JournalRinsho byori. The Japanese journal of clinical pathology
Volume63
Issue number4
Publication statusPublished - 01-04-2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Mass Screening for Inborn Errors of Metabolism'. Together they form a unique fingerprint.

  • Cite this